Ryman Healthcare Ltd
F:RH70
Ryman Healthcare Ltd
F:RH70
Price:
5.1
EUR
Market Cap:
€5.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ryman Healthcare Ltd
F:RH70
|
NZ |
|
K
|
Kreate Group Oyj
F:16T
|
FI |
|
B
|
British American Tobacco PLC
XBER:BMT
|
UK |
|
Margaret Lake Diamonds Inc
F:M850
|
CA |
|
S
|
Scentre Group
F:59S
|
AU |
|
Mitsui & Co Ltd
OTC:MITSF
|
JP |
|
P
|
Paychex Inc
XBER:PCX
|
US |
|
B
|
British American Tobacco PLC
DUS:BMT
|
UK |
|
P
|
Plant Health Care PLC
F:PC5
|
US |
|
F
|
F5 Inc
XBER:FFV
|
US |
|
F
|
FormFactor Inc
F:FMF
|
US |
|
ePlus inc
NASDAQ:PLUS
|
US |
|
S
|
Sagax AB
F:EFE
|
SE |
|
Capitaland Investment Ltd
F:5NU
|
SG |
|
I
|
Intesa Sanpaolo SpA
BMV:ISPN
|
IT |
|
I
|
Intesa Sanpaolo SpA
DUS:IES
|
IT |
|
Lenzing AG
F:LEN
|
AT |
|
C
|
Coca-Cola Europacific Partners PLC
AEX:CCEP
|
UK |
|
B
|
Beazer Homes USA Inc
F:BE4A
|
US |
|
M
|
Marathon Petroleum Corp
XBER:MPN
|
US |
|
O
|
Orlen SA
XMUN:PKY1
|
PL |
|
S
|
Stora Enso Oyj
XMUN:ENUA
|
FI |
|
Biogaia AB
F:BGL
|
SE |
Wall St Price Targets
RH70 Price Targets Summary
Ryman Healthcare Ltd
Ryman Healthcare Ltd
Wall Street analysts forecast RH70 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for RH70 is 6.98 EUR with a low forecast of 6.25 EUR and a high forecast of 8.15 EUR.
Lowest Forecast
Price Target
6.25
EUR
22% Upside
Average Forecast
Price Target
6.98
EUR
37% Upside
Highest Forecast
Price Target
8.15
EUR
60% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RH70's stock price target?
Price Target
6.98
EUR
6.98
EUR
According to Wall Street analysts, the average 1-year price target for RH70 is 6.98 EUR with a low forecast of 6.25 EUR and a high forecast of 8.15 EUR.
What is the Revenue forecast for Ryman Healthcare Ltd?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 8%.
